RAY1225 for weight loss in obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational medication called RAY1225 in people with obesity. It's given as an injection and may help with weight loss by targeting hormones that control appetite.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a high body weight: a BMI of 28 or more, or a BMI of 24 or more with at least one weight-related health problem like high blood pressure, sleep apnea, or early signs of diabetes.
- You must be willing to use reliable contraception (like birth control pills, condoms, or an IUD) during the study and for 6 months after the last dose of the study drug.
- You cannot have diabetes or a history of low blood sugar (hypoglycemia).
- You must not have a personal or family history of medullary thyroid cancer (a rare type of thyroid cancer) or a genetic condition called Multiple Endocrine Neoplasia type 2.
- You cannot have had weight-loss surgery (except liposuction or tummy tuck more than 1 year ago).
- You must be able to receive injections under the skin (the study drug is given as a shot) and cannot have severe allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called RAY1225 to help people lose weight. If you have obesity or are overweight with related health conditions, you may be able to join.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.